Holding(s) in Company
NLC Health Impact Fund Coöperatief U.A. has acquired a significant stake in Thalia Therapeutics PLC, crossing a notification threshold on July 20, 2026. The fund now holds 3.86% of the company's voting rights, representing 68,600,877 ordinary shares. This marks a substantial increase from their previous holding of 0.00%. The notification was made on July 21, 2026, and NLC Health Impact Fund confirms it is not controlled by any other entity and does not control any other undertakings holding an interest in Thalia Therapeutics PLC.
Select text to share a quote on X · sign in to keep highlights & notes in your THAT notes
Non-UK issuer
- Reason for the notification (please mark the appropriate box or boxes with an "X")
| An acquisition or disposal of voting rights | X |
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) iii :
Details of person subject to the notification obligation iv
| Name | NLC Health Impact Fund Coöperatief U.A. |
| City and country of registered office (if applicable) | Amsterdam, Netherlands |
Full name of shareholder(s) (if different from 3.) v
Name
City and country of registered office (if applicable)
| 5. Date on which the threshold was crossed or reached vi : | 20 July 2026 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 21 July 2026 |
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 3.86% | 3.86% | 68,600,877 |
| Position of previous notification (if applicable) | 0.00% | 0.00% | 0 |
| A: Voting rights attached to shares | |||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | |
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) |
| Ordinary shares of 0.4p (GB00BYW8QM32) | 68,600,877 | 3.86% | |
| SUBTOTAL 8. A | 68,600,877 | 3.86% | |
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
SUBTOTAL 8.B.2
In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional information xvi
| Place of completion | London, AIM Market |
| Date of completion | 20 July 2026 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.